In line with the view that SAM prevents the development of liver cancer, the expression of PNPLA7, as well as several enzymes in the choline/methionine metabolism, is reduced in human hepatocellular carcinoma. The gene discussed is PNPLA7; the disease is hepatocellular carcinoma.